Importantly, our study showing that PAD2 inhibition with Cl-amidine can partially restore the sensitivity of TamR/MCF7 cells to tamoxifen suggests that Cl-amidine may represent a new candidate for breast cancer therapy. This evidence concerns the gene PADI2 and breast carcinoma.